Bone Marrow Cells Differentiate in Cardiac Cell Lineages After Infarction Independently of Cell Fusion

Recent studies in mice have challenged the ability of bone marrow cells (BMCs) to differentiate into myocytes and coronary vessels. The claim has also been made that BMCs acquire a cell phenotype different from the blood lineages only by fusing with resident cells. Technical problems exist in the in...

Full description

Saved in:
Bibliographic Details
Published inCirculation Research Vol. 96; no. 1; pp. 127 - 137
Main Authors Kajstura, Jan, Rota, Marcello, Whang, Brian, Cascapera, Stefano, Hosoda, Toru, Bearzi, Claudia, Nurzynska, Daria, Kasahara, Hideko, Zias, Elias, Bonafé, Massimiliano, Nadal-Ginard, Bernardo, Torella, Daniele, Nascimbene, Angelo, Quaini, Federico, Urbanek, Konrad, Leri, Annarosa, Anversa, Piero
Format Journal Article
LanguageEnglish
Published Hagerstown, MD American Heart Association, Inc 07.01.2005
Lippincott
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent studies in mice have challenged the ability of bone marrow cells (BMCs) to differentiate into myocytes and coronary vessels. The claim has also been made that BMCs acquire a cell phenotype different from the blood lineages only by fusing with resident cells. Technical problems exist in the induction of myocardial infarction and the successful injection of BMCs in the mouse heart. Similarly, the accurate analysis of the cell populations implicated in the regeneration of the dead tissue is complex and these factors together may account for the negative findings. In this study, we have implemented a simple protocol that can easily be reproduced and have reevaluated whether injection of BMCs restores the infarcted myocardium in mice and whether cell fusion is involved in tissue reconstitution. For this purpose, c-kit–positive BMCs were obtained from male transgenic mice expressing enhanced green fluorescence protein (EGFP). EGFP and the Y-chromosome were used as markers of the progeny of the transplanted cells in the recipient heart. By this approach, we have demonstrated that BMCs, when properly administrated in the infarcted heart, efficiently differentiate into myocytes and coronary vessels with no detectable differentiation into hemopoietic lineages. However, BMCs have no apparent paracrine effect on the growth behavior of the surviving myocardium. Within the infarct, in 10 days, nearly 4.5 million biochemically and morphologically differentiated myocytes together with coronary arterioles and capillary structures were generated independently of cell fusion. In conclusion, BMCs adopt the cardiac cell lineages and have an important therapeutic impact on ischemic heart failure.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0009-7330
1524-4571
1524-4539
DOI:10.1161/01.RES.0000151843.79801.60